Thymosin Beta-4 (TB-500)

Thymosin Beta-4 (TB-500) is a synthetic peptide derived from the naturally occurring 43-amino acid protein thymosin β4. It promotes tissue repair and wound healing by enhancing cell migration, angiogenesis, and reducing inflammatory cytokine expression.

Origin & History

Thymosin Beta-4 (TB-500) is a synthetic version of a naturally occurring peptide involved in tissue repair and regeneration. It is produced through peptide synthesis, ensuring high purity for therapeutic use.

Historical & Cultural Context

Thymosin Beta-4 was identified in the 1960s and has been studied for its regenerative properties, particularly in sports medicine and injury recovery.

Health Benefits

- Accelerates wound healing and tissue repair by promoting cell migration and angiogenesis, leading to faster recovery from injuries. - Reduces inflammation by modulating cytokine activity, which helps decrease pain and swelling. - Promotes recovery from injuries by supporting muscle and tendon regeneration. - Enhances blood vessel formation, improving nutrient delivery to damaged tissues. - Supports immune function by regulating white blood cell activity, aiding in defense against infection. - May reduce scar tissue formation by balancing collagen deposition during healing. - Improves flexibility and mobility by supporting connective tissue health. - Protects against oxidative stress by boosting antioxidant enzyme activity, preserving cellular integrity.

How It Works

TB-500 binds to actin proteins and promotes actin polymerization, facilitating cell migration and tissue remodeling. It upregulates VEGF (vascular endothelial growth factor) expression to stimulate angiogenesis and new blood vessel formation. The peptide also modulates inflammatory pathways by reducing pro-inflammatory cytokines like TNF-α and IL-1β while promoting anti-inflammatory mediators.

Scientific Research

Animal studies and preliminary human research highlight TB-500's role in tissue repair and inflammation reduction. More clinical trials are needed to establish its efficacy in humans.

Clinical Summary

Most research on TB-500 consists of preclinical animal studies rather than large-scale human trials. Animal studies have demonstrated accelerated wound healing, improved muscle regeneration, and reduced inflammation with dosages typically ranging from 2-10mg administered twice weekly. Limited human case reports suggest potential benefits for injury recovery, but controlled clinical trials in humans are lacking. The current evidence base is promising but insufficient to establish definitive therapeutic protocols or safety profiles in humans.

Nutritional Profile

- Composed of 43 amino acids.
- Contains no calories, fats, or carbohydrates.
- Available in injectable form for targeted delivery.

Preparation & Dosage

Typically administered in doses of 2-5 mg per week. Consult a healthcare provider before use.

Synergy & Pairings

Collagen, Glutamine, Vitamin D

Safety & Interactions

TB-500 may cause injection site reactions, fatigue, and temporary flu-like symptoms in some users. Drug interactions are not well-documented due to limited human studies, though caution is advised with anticoagulant medications as TB-500 may affect blood clotting. The peptide is contraindicated in individuals with active cancer due to its angiogenic properties potentially promoting tumor growth. Safety during pregnancy and breastfeeding is unknown and use should be avoided.